FM
Insider
Fady Ibraham Malik
EVP Research & DevelopmentFady Ibraham Malik (EVP Research & Development) filed 18 Form 4 reports in the trailing twelve months (0 purchases, 18 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $748K of CYTK (12,033 sh across 2 lots, as filed), executed Mar 17.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
18
0 buys · 18 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.4M
shares × price, as filed
Last traded
Sep 8
Filed Sep 8
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
18 filings
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$230K3,500 sh × $65.69
Exec Apr 21
Filed Apr 21 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $228K
3,500 sh × $65.21
Exec Apr 7
Filed Apr 8 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $748K
12,033 sh across 2 lots
Exec Mar 17
Filed Mar 18 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $177K
2,907 sh × $60.72
Exec Mar 9
Filed Mar 10 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $135K
2,200 sh × $61.24
Exec Dec 16 2025
Filed Dec 16 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $141K
2,200 sh × $63.89
Exec Dec 2 2025
Filed Dec 2 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $146K
2,200 sh × $66.45
Exec Nov 18 2025
Filed Nov 18 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $137K
2,295 sh × $59.55
Exec Nov 4 2025
Filed Nov 4 2025 · 5:30 PM ET More filings →